Skip to main content

23000Ul Axca (Ultresa 46,000 USP units amylase; 23,000 USP units lipase; 46,000 USP units protease)

Generic Name: pancrelipase

Pill with imprint 23000Ul Axca is Gray / Yellow, Capsule-shape and has been identified as Ultresa 46,000 USP units amylase; 23,000 USP units lipase; 46,000 USP units protease. It is supplied by Allergan, Inc.

Ultresa is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultresa 46,000 USP units amylase; 23,000 USP units lipase; 46,000 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for 23000Ul Axca

Ultresa

Generic Name
pancrelipase
Imprint
23000Ul Axca
Strength
46,000 USP units amylase; 23,000 USP units lipase; 46,000 USP units protease
Color
Gray / Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Allergan, Inc.
National Drug Code (NDC)
58914-0005 (Discontinued)
Inactive Ingredients
silicon dioxide, croscarmellose sodium, hydrogenated castor oil, hypromellose phthalate, magnesium stearate, microcrystalline cellulose, magnesium silicate, triethyl citrate, gelatin, titanium dioxide, ferric oxide yellow, ferrosoferric oxide, shellac, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.